|
1
|
Carling T and Udelsman R: Thyroid cancer.
Annu Rev Med. 65:125–137. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fagin JA and Wells SA Jr: Biologic and
clinical perspectives on thyroid cancer. N Engl J Med.
375:1054–1067. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sipos JA and Mazzaferri EL: Thyroid cancer
epidemiology and prognostic variables. Clin Oncol (R Coll Radiol).
22:395–404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kunavisarut T: Diagnostic biomarkers of
differentiated thyroid cancer. Endocrine. 44:616–622. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li J, Tian H, Yang J and Gong Z: Long
noncoding RNAs regulate cell growth, proliferation, and apoptosis.
DNA Cell Biol. 35:459–470. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lv W, Wang L, Lu J, Mu J, Liu Y and Dong
P: Long noncoding RNA KIAA0125 potentiates cell migration and
invasion in gallbladder cancer. BioMed Res Int. 2015:1084582015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu L, Yang J, Zhu X, Li D, Lv Z and Zhang
X: Long noncoding RNA H19 competitively binds miR-17-5p to regulate
YES1 expression in thyroid cancer. FEBS J. 283:2326–2339. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dai W, Tian Y, Jiang B and Chen W:
Down-regulation of long non- coding RNA AFAP1-AS1 inhibits tumor
growth, promotes apoptosis and decreases metastasis in thyroid
cancer. Biomed Pharmacother. 99:191–197. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu W, Xu Y, Xu J, Wang Z and Ye G:
Identification of differential expressed lncRNAs in human thyroid
cancer by a genome-wide analyses. Cancer Med. 7:3935–3944. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun M, Nie FQ, Zang C, Wang Y, Hou J, Wei
C, Li W, He X and Lu KH: The Pseudogene DUXAP8 promotes
non-small-cell lung cancer cell proliferation and invasion by
epigenetically silencing EGR1 and RHOB. Mol Ther. 25:739–751. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lian Y, Yang J, Lian Y, Xiao C, Hu X and
Xu H: DUXAP8, a pseudogene derived lncRNA, promotes growth of
pancreatic carcinoma cells by epigenetically silencing CDKN1A and
KLF2. Cancer Commun (Lond). 38:642018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen J, Lou W, Ding B and Wang X:
Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of
renal cell carcinoma and serve as unfavorable prognostic
biomarkers. Aging (Albany NY). 11:5666–5688. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thomson DW and Dinger ME: Endogenous
microRNA sponges: Evidence and controversy. Nat Rev Genet.
17:272–283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han P, Li J, Zhang B, Lv J, Li Y, Gu X, Yu
Z, Jia Y, Bai X, Li L, et al: The lncRNA CRNDE promotes colorectal
cancer cell proliferation and chemoresistance via
miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol
Cancer. 16:92017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ba Z, Gu L, Hao S, Wang X, Cheng Z and Nie
G: Downregulation of lncRNA CASC2 facilitates osteosarcoma growth
and invasion through miR-181a. Cell Prolif. 51:e124092018.
View Article : Google Scholar
|
|
18
|
Jazdzewski K, Liyanarachchi S, Swierniak
M, Pachucki J, Ringel Md, Jarzab B and de la chapelle A:
Polymorphic mature microRNAs from passenger strand of pre-miR-146a
contribute to thyroid cancer. Proc Natl Acad Sci USA.
106:1502–1505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li M, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Edge SB, Byrd DR, Compton CC, Fritz AG and
Greene FL: AJCC Cancer Staging Manual. 7th edition. Springer; New
York, NY: 2010
|
|
21
|
Rau A, Flister M, Rui H and Auer PL:
Exploring drivers of gene expression in the Cancer Genome Atlas.
Bioinformatics. 35:62–68. 2019.PubMed/NCBI
|
|
22
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Research.
45:W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deschenes-Simard X, Kottakis F, Meloche S
and Ferbeyre G: ERKs in cancer: Friends or foes? Cancer Res.
74:412–419. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hong S, Yu S, Li J, Yin Y, Liu Y, Zhang Q,
Guan H, Li Y and Xiao H: MiR-20b displays tumor-suppressor
functions in papillary thyroid carcinoma by regulating the MAPK/ERK
signaling pathway. Thyroid. 26:1733–1743. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang Y: The novel regulatory role of
lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med.
22:5768–5775. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Harrow J, Frankish A, Gonzalez JM,
Tapanari E, Diekhans M, Kokocinski F, Aken BL, Barrell D, Zadissa
A, Searle S, et al: GENCODE: The reference human genome annotation
for The ENCODE Project. Genome Res. 22:1760–1774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cargnello M and Roux PP: Activation and
function of the MAPKs and their substrates, the MAPK-activated
protein kinases. Microbiol Mol Biol Rev. 75:50–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Peyret V, Nazar M, Martín M, Quintar AA,
Fernandez EA, Geysels RC, Fuziwara CS, Montesinos MM, Maldonado CA,
Santisteban P, et al: Functional toll-like receptor 4
overexpression in papillary thyroid cancer by MAPK/ERK-induced ETS1
transcriptional activity. Mol Cancer Res. 16:833–845. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Swierniak M, Wojcicka A, Czetwertynska M,
Stachlewska E, Maciag M, Wiechno W, Gornicka B, Bogdanska M,
Koperski L, de la Chapelle A and Jazdzewski K: In-depth
characterization of the microRNA transcriptome in normal thyroid
and papillary thyroid carcinoma. J Clin Endocrinol Metab.
98:E1401–E1409. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jahanbani I, Al-Abdallah A, Ali RH,
Al-Brahim N and Mojiminiyi O: Discriminatory miRNAs for the
management of papillary thyroid carcinoma and noninvasive
follicular thyroid neoplasms with papillary-like nuclear features.
Thyroid. 28:319–327. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qi P, Xu MD, Shen XH, Ni SJ, Huang D, Tan
C, Weng WW, Sheng WQ, Zhou XY and Du X: Reciprocal repression
between TUSC7 and miR-23b in gastric cancer. Int J Cancer.
137:1269–1278. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang O, Huang Y, Wu H, Zheng B, Lin J and
Jin P: lncRNA LOC728196/miR-513c axis facilitates glioma
carcinogenesis by targeting TCF7. Gene. 679:119–125. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tan J, Qiu K, Li M and Liang Y:
Double-negative feedback loop between long non-coding RNA TUG1 and
miR-145 promotes epithelial to mesenchymal transition and
radioresistance in human bladder cancer cells. FEBS Lett.
589:3175–3181. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
De S, Dermawan JK and Stark GR: EGF
receptor uses SOS1 to drive constitutive activation of B in cancer
cells. Proc Natl Acad Sci USA. 111:11721–11726. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen H, Wu X, Pan ZK and Huang S:
Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer
metastasis. Cancer Res. 70:9979–9990. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang M, Wu Q, Fang M, Huang W and Zhu H:
miR-152-3p sensitizes glioblastoma cells towards cisplatin via
regulation of SOS1. Onco Targets Ther. 12:9513–9525. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang H, Dong L, Gong F, Gu Y, Zhang H,
Fan D and Sun Z: Inflammatory genes are novel prognostic biomarkers
for colorectal cancer. Int J Mol Med. 42:368–380. 2018.PubMed/NCBI
|
